Education
About Us
Working with TipRanks
Follow Us
Benjamin Machinas Beneski Insider Profile
4 Followers
Benjamin Machinas Beneski, SVP, CTO at Allogene Therapeutics, holds 218.51K shares in Allogene Therapeutics (Ticker: ALLO).
Benjamin Machinas Beneski has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Benjamin Machinas Beneski's holdings
Insider Roles
SVP, CTO
Roles that Benjamin Machinas Beneski holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Benjamin Machinas Beneski
Benjamin Machinas Beneski's Trading History
List of latest transactions for each holding click on a transaction to see Benjamin Machinas Beneski's performance on stock
You May Also Like
Benjamin Machinas Beneski insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Machinas Beneski?
The percentage of profitable transactions made by Benjamin Machinas Beneski is ―.
What is the average return per transaction made by Benjamin Machinas Beneski?
The average return per transaction made by Benjamin Machinas Beneski is ―.
What stocks does Benjamin Machinas Beneski hold?
Benjamin Machinas Beneski holds: ALLO stocks.
What was Benjamin Machinas Beneski’s latest transaction?
Benjamin Machinas Beneski latest transaction was an Uninformative Sell of $10.81K.
What was Benjamin Machinas Beneski's most profitable transaction?
Benjamin Machinas Beneski’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Benjamin Machinas Beneski's role in Allogene Therapeutics?
Benjamin Machinas Beneski's role in Allogene Therapeutics is SVP, CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.